Table 2.
Year | Team | Materials | Results |
---|---|---|---|
2017 | Fernandes et al. [79] | Mg and Sr-substituted BGs | Increased osteogenic differentiation and expression of ALP, OPN, and OCN in BMSCs |
2018 | Naruphontjirakul et al. [69] | Sr-containing BG nanoparticles | Increased ALP activity and expression of OCN in MC3T3-E1 |
2018 | Fiorilli et al. [72] | Sr-BGs | Increased osteogenic differentiation of SAOS-2 |
2018 | Midha et al. [78] | Sr-BGs | Increased osteogenic differentiation of BMSCs |
2019 | Autefage et al. [75] | PSrBG | Increased proliferation of BMSCs and MC3T3-E1 |
2019 | Shaltooki et al. [76] | BGs composed of PCL and different levels of Sr | Increased osteogenic activity of MG-63 |
2020 | Huang et al. [49] | Sr-substituted BGs | Inhibited RANKL-mediated osteoclastogenesis |
2021 | Baheiraei et al. [70] | Gel-BG/Sr scaffolds | Increased bone formation |
2021 | Fiorilli et al. [73] | Sr-containing esoporous BGs | Inhibited osteoclast differentiation and function |
2022 | Wu et al. [74] | Sr-BG | Increased osteogenesis and angiogenesis of BMSCs |
ALP: alkaline phosphatase, BMSCs: bone marrow mesenchymal stem cells, BGs: bioactive glasses, Gel-BG: gelatin-bioactive glasses, OPN: osteopontin, OCN: osteocalcin, PCL: polycaprolactone, PSrBG: porous, Sr-releasing and bioactive glass-based scaffold, RANKL: receptor activator of nuclear factor-κB ligand.